Beam grants 20,000 RSUs to finance SVP
Cavanagh Bethany J reported acquisition or exercise transactions in this Form 4 filing.
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Cavanagh Bethany J reported acquisition or exercise transactions in this Form 4 filing.
Beam Therapeutics reported that SVP, Finance and Treasurer Bethany J. Cavanagh received a grant of 20,000 restricted stock units under the company’s 2019 Equity Incentive Plan. Each RSU represents one share of common stock and vests in four equal annual installments, subject to continued service. Following this award, she holds 54,813 shares directly.
Insider Trade Summary
Grant/Award: 20,000 shares
Grant/Award
1 txn
Insider
Cavanagh Bethany J
Role
SVP, Finance and Treasurer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 20,000 | $0.00 | $0.00 |
Holdings After Transaction:
Common Stock — 54,813 shares (Direct)
Holdings Before and After:
Common Stock, 34,813 to 54,813 shares (Direct)
Footnotes (1)
- F1. Represents restricted stock units ("RSUs") granted to the Reporting Person under the Beam Therapeutics Inc. ("BEAM") 2019 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of BEAM's common stock. The RSUs vest in four substantially equal installments on each of the first four anniversaries of the date of grant, subject to the Reporting Person's continued service with BEAM through each vesting date.
Key Figures
RSU grant size: 20,000 RSUs
Post-transaction holdings: 54,813 shares
Vesting schedule: 4 annual installments
+1 more
4 metrics
RSU grant size
20,000 RSUs
Equity award to SVP, Finance and Treasurer
Post-transaction holdings
54,813 shares
Total common stock held directly after grant
Vesting schedule
4 annual installments
RSUs vest over first four anniversaries of grant
Grant price per RSU
$0.0000 per unit
Compensation award, not an open-market purchase
Key Terms
restricted stock units ("RSUs"), 2019 Equity Incentive Plan, contingent right, vest
4 terms
restricted stock units ("RSUs") financial
"Represents restricted stock units ("RSUs") granted to the Reporting Person"
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
2019 Equity Incentive Plan financial
"granted to the Reporting Person under the Beam Therapeutics Inc. ("BEAM") 2019 Equity Incentive Plan"
contingent right financial
"Each RSU represents the contingent right to receive one share"
vest financial
"The RSUs vest in four substantially equal installments"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did BEAM report for Bethany J. Cavanagh?
Beam Therapeutics reported that SVP, Finance and Treasurer Bethany J. Cavanagh received 20,000 restricted stock units as an equity award. These RSUs were granted under the 2019 Equity Incentive Plan and increase her direct holdings to 54,813 shares of common stock.
What are the terms of Bethany Cavanagh’s 20,000 BEAM RSU grant?
The 20,000 RSUs granted to Bethany Cavanagh each represent the right to receive one Beam Therapeutics common share. They vest in four substantially equal installments on each of the first four anniversaries of the grant date, conditioned on her continued service with the company.
Is Bethany Cavanagh’s BEAM Form 4 transaction a purchase or a compensation grant?
The Form 4 shows a compensation-related grant, not an open-market purchase. Bethany Cavanagh received 20,000 restricted stock units at a price of $0.0000 per unit, reflecting an award under Beam Therapeutics’ 2019 Equity Incentive Plan rather than a cash transaction in the market.
How do the BEAM RSUs granted to Bethany Cavanagh convert into common stock?
Each RSU granted to Bethany Cavanagh represents a contingent right to receive one share of Beam Therapeutics common stock. As the RSUs vest in four equal annual installments, and if she remains in service, the vested units settle into shares that increase her actual share ownership.
What plan governs Bethany Cavanagh’s 20,000 BEAM restricted stock units?
The 20,000 restricted stock units granted to Bethany Cavanagh were issued under the Beam Therapeutics Inc. 2019 Equity Incentive Plan. This plan provides equity-based compensation, such as RSUs, to employees and typically includes vesting conditions tied to ongoing service with the company.
AI-generated analysis. How Rhea-AI works. Not financial advice.
